USE OF TRANSCATHETER PULMONARY VALVE REPLACEMENT ACROSS THE AGE SPAN OF PATIENTS WITH CONGENITAL HEART DISEASE: A REPORT FROM THE NCDR IMPACT REGISTRY

Transcatheter pulmonary valve replacement (TPVR) was approved in 2015. Real world practice, including patient selection, outcomes and complications, in patients who may not meet the trial instructions for use, is not well known. Demographics, procedural characteristics and outcomes were collected